|
|
Jean B. Regard, Hiroshi Kataoka, David A. Cano, Eric Camerer, Liya Yin, Yao-Wu Zheng, Thomas S. Scanlan, Matthias Hebrok, Shaun R. Coughlin
J Clin Invest. 2007;
117(12):4034
doi:10.1172/JCI32994
Abstract |
Full text
| PDF
| Supplemental material

T
he in vivo roles of the hundreds of mammalian G protein–coupled receptors (GPCRs) are incompletely understood. To explore these roles, we generated mice expressing the S1 subunit of pertussis toxin, a known inhibitor of Gi/o signaling, under the control of the ROSA26 locus in a Cre recombinase–dependent manner (ROSA26PTX). Crossing ROSA26PTX mice to mice expressing Cre in pancreatic β cells produced offspring with constitutive hyperinsulinemia, increased insulin secretion in response to glucose, and resistance to diet-induced hyperglycemia. This phenotype underscored the known importance of Gi/o and hence of GPCRs for regulating insulin secretion. Accordingly, we quantified mRNA for each of the approximately 373 nonodorant GPCRs in mouse to identify receptors highly expressed in islets and examined the role of several. We report that 3-iodothyronamine, a thyroid hormone metabolite, could negatively and positively regulate insulin secretion via the Gi-coupled α2A-adrenergic receptor and the Gs-coupled receptor Taar1, respectively, and protease-activated receptor–2 could negatively regulate insulin secretion and may contribute to physiological regulation of glucose metabolism. The ROSA26PTX system used in this study represents a new genetic tool to achieve tissue-specific signaling pathway modulation in vivo that can be applied to investigate the role of Gi/o-coupled GPCRs in multiple cell types and processes.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(4)
| Title and authors |
Publication |
Year |
Augmented glucose-induced insulin release in mice lacking Go2, but not Go1 or Gi proteins
Y. Wang, S. Park, N. S. Bajpayee, Y. Nagaoka, G. Boulay, L. Birnbaumer, M. Jiang
|
Proceedings of the National Academy of Sciences
|
2011 |
Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone
J. R. Muppidi, T. I. Arnon, Y. Bronevetsky, N. Veerapen, M. Tanaka, G. S. Besra, J. G. Cyster
|
Journal of Experimental Medicine
|
2011 |
RGS4 is a negative regulator of insulin release from pancreatic -cells in vitro and in vivo
I. Ruiz de Azua, M. Scarselli, E. Rosemond, D. Gautam, W. Jou, O. Gavrilova, P. J. Ebert, P. Levitt, J. Wess
|
Proceedings of the National Academy of Sciences
|
2010 |
A chemical-genetic approach to study G protein regulation of cell function in vivo
J.-M. Guettier, D. Gautam, M. Scarselli, I. R. de Azua, J. H. Li, E. Rosemond, X. Ma, F. J. Gonzalez, B. N. Armbruster, H. Lu, B. L. Roth, J. Wess
|
Proceedings of the National Academy of Sciences
|
2009 |
|